morning traders 17 / 05, page-162

  1. Anderson101
    996 Posts.
    lightbulb Created with Sketch. 55
    clock Created with Sketch.
    17/05/19
    10:46
    Post #: 38610754
    NEU
    - It's drug has enabled complete treatment of Angelman Syndrome and PTHS in a pre-clinical model, where there is no current treatment available.
    - Should go up to $2-3 today, should have a fomo run maybe in the afternoon, like we saw with OCC when they released its announcement.
    - Biotech sector's hot, stock was trading almost $4 not too long ago
    https://hotcopper.com.au/data/attachments/1552/1552848-3774206c22539ece836abd278acd93f0.jpg
    Likes Created with Sketch. 1  Upvote
    Stroke 3 Created with Sketch. Comments Created with Sketch. Reply

  2. Top Stories

 

Featured News

CMX ChemX Materials kicks off first stage works at WA high purity alumina pilot
right-arrow Created with Sketch.
TBN Tamboran is developing the NT Beetaloo Basin. To get there, it's listing at $36/sh on the NYSE
right-arrow Created with Sketch.
LYC Lynas eyes first dysprosium, terbium HREE production in CY25
right-arrow Created with Sketch.
SVL Silver Mines models five new calderas close to 396Moz Bowdens deposit
right-arrow Created with Sketch.
3DP Pointerra wins US$1.63M from US Dept of Energy to model climate change scenarios
right-arrow Created with Sketch.
ABY Adore Beauty buys up wellness brand iKOU for $25M cash
right-arrow Created with Sketch.
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.